Insulin-to-C-Peptide Ratio

Purpose: To use the ratio of insulin to C-peptide to help separate insulinoma from exogenous insulin administration.

Info MyLikes MyPaths

Evaluation

Serum insulin level

Serum C-peptide level

Is a sulfonylurea detected in the serum?

Yes

Does the patient have renal failure?

Yes

Does the patient have liver disease?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Insulin to C-peptide ratio

Which indicates

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Laboratory Tests

Therapy

Dosage Adjustments
Administration
Prevention
- Treat-to-Target Insulin Titration Schedule for Patient with Type 2 Diabetes

Monitoring

Adverse Effects
- Treat-to-Target Insulin Titration Schedule for Patient with Type 2 Diabetes

Specialty

Endocrinology
Clinical Laboratory

Objective

laboratory tests

ICD-10

E16.2 - Hypoglycaemia, unspecified
T38.3 - Poisoning, insulin and oral hypoglycaemic [antidiabetic] drugs
D37.7 - Neoplasm of uncertain or unknown behaviour, other digestive organs

Info

Purpose: To use the ratio of insulin to C-peptide to help separate insulinoma from exogenous insulin administration.

Specialty: Endocrinology, Clinical Laboratory

Objective: laboratory tests

ICD-10: E16.2, T38.3, D37.7,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path